Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
<h4>Background</h4>In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure and alterations in geometry have not been systematically evaluated.<h4>Methods</h4&g...
Main Authors: | Johannes Krämer, Bart Bijnens, Stefan Störk, Christian O Ritter, Dan Liu, Georg Ertl, Christoph Wanner, Frank Weidemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0140627 |
Similar Items
-
High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
by: Nora Seydelmann, et al.
Published: (2016-06-01) -
Impact of regional left ventricular function on outcome for patients with AL amyloidosis.
by: Dan Liu, et al.
Published: (2013-01-01) -
Fabry Cardiomyopathy: Current Treatment and Future Options
by: Irfan Vardarli, et al.
Published: (2021-07-01) -
Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.
by: Nurcan Üçeyler, et al.
Published: (2016-01-01) -
Left Ventricular Geometry and Replacement Fibrosis Detected by cMRI Are Associated with Major Adverse Cardiovascular Events in Nonischemic Dilated Cardiomyopathy
by: Bianca Olivia Cojan-Minzat, et al.
Published: (2020-06-01)